Panagora Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Panagora Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-9,561	Closed	-$878K	–	2371
2017 Q4	$878K	Buy	+9,561	New	+$546K	﹤0.01%	1187
2017 Q2	–	Sell	-533	Closed	-$8K	–	2637
2017 Q1	$8K	Sell	533 -2,746	-84%	-$43.2K	﹤0.01%	2277
2016 Q4	$49K	Hold	3,279	–	–	﹤0.01%	2106
2016 Q3	$42K	Buy	+3,279	New	+$31.8K	﹤0.01%	2152
2016 Q2	–	Sell	-17,674	Closed	-$148K	–	2326
2016 Q1	$148K	Sell	17,674 -1,099	-6%	-$9.18K	﹤0.01%	1754
2015 Q4	$231K	Buy	18,773 +5,487	+41%	+$151K	﹤0.01%	1554
2015 Q3	$809K	Buy	13,286 +2,469	+23%	+$178K	﹤0.01%	1124
2015 Q2	$844K	Buy	+10,817	New	+$908K	﹤0.01%	1167
2014 Q2	–	Sell	-8	Closed	-$1K	–	2357
2014 Q1	$1K	Buy	+8	New	+$1.58K	﹤0.01%	2326

Other funds holding MDGL

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Panagora Asset Management's MDGL Position: Q1 2018 in Review

Panagora Asset Management sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2018, closing a stake of 9,561 shares — an estimated $878K sold.

Panagora Asset Management first reported a position in MDGL in Q1 2014 and held it in 9 quarters. The position peaked at $878K in Q4 2017. 100 funds tracked by Wall St. Rank hold MDGL as of Q1 2018.

Panagora Asset Management reported no remaining Madrigal Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Panagora Asset Management sold 9,561 Madrigal Pharmaceuticals shares in Q1 2018, an estimated $878K.
Panagora Asset Management first reported a position in Madrigal Pharmaceuticals in Q1 2014 and held it in 9 quarters.
Panagora Asset Management's Madrigal Pharmaceuticals position peaked at $878K in Q4 2017.
100 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2018.

Based on Panagora Asset Management's 13F filing for Q1 2018, filed 15 May 2018.